IAS News and Literature Updates:
May and June 2019


From the President's Desk:

Raul Santos
As President of the IAS I am very proud to Welcome You to the New IAS Website!
I hope you like it and consider it as a reliable source of information. We look forward to receiving many comments from our readers so to improve, update, and broaden the content.
The IAS is a global entitiy and the IAS website should represent all the excellencs, diversities and commonalities of our network.
It is important that we all work together and share experiences.
Thanks you for your support.
Raul Santos



            IAS NEW ACTIVITIES         

IAS and R3i Foundation publish new consensus on SPPARMα
The International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation announce a Joint Consensus Statement on Selective Peroxisome Proliferator Activated Receptor alpha Modulators (SPPARMα)
This Joint Consensus statement is published by Cardiovascular Diabetology:
http://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-019-0864-7
We are happy to inform that the excellent article has an outstanding number of the accesses: 2150 during only 3 weeks since publication (This metric reflects only the publisher website, maybe even more accesses could be expected from PubMed directly.)
News from this IAS-R3i Consensus Panel Statement will be discussed at a Press Conference in Paris on September 1, 2019.

 

*******************

Visceral obesity as a risk factor for chronic societal disease is being recognized in a global consensus paper published in the prestigious medical journal
The Lancet Diabetes & Endocrinology


In 1963, using computed tomography, an imaging technique that was not used at the time for measuring body fat, a team of researchers from the Department of Internal Medicine at Osaka University led by Prof. Yuji Matsuzawa showed for the first time that there were substantial individual differences in the way human beings would store their body fat. Indeed, these Japanese researchers published fascinating images showing that despite similar body weights, some people would accumulate significant amounts of fat in their abdominal cavity, this fat being invisible from outside the body.  They called that fat visceral fat and its excess, visceral obesity. In 1986, intrigued by these findings and at the very beginning of his career as an independent researcher at Université Laval, Prof. Jean-Pierre Després of the Department of Kinesiology at the Faculty of Medicine, launched with his colleagues a series of imaging studies where computed tomography would also be systematically used to assess the distribution of body fat (including abdominal fat) and its relationship to health outcomes. Soon enough, at the dawn of the 1990s, his team reported results that clearly showed the limits of the ideal body weight concept (body mass index) and the key importance of visceral fat (the fat located in the abdominal cavity) as a risk factor for chronic diseases such as cardiovascular diseases and type 2 diabetes.
Read more

 

*******************

We are pleased to announce that the International Atherosclerosis Society (IAS) and the Oman Society of Lipid & Atherosclerosis (OSLA) will organize the 6th IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk to be held in Muscat (Oman) in February 2020.
 

*******************

7th  IAS-Weill Cornell Seminar on Lipid Metabolism and Cardiovascular Risk, Salzburg, Austria, November 3-9, 2019.

The residential Seminar is directed to physicians practicing in Central and Eastern Europe, Central Asia, the former Soviet Union and other countries in transition. The Seminar is organized jointly by the IAS, Weill Cornel Medical College, and the American Austrian Foundation. For further information please link to http://www.aaf-online.org/

Also included in this Newsletter:

In the News:
 
   XIX International Symposium on Atherosclerosis 2021  

 

 Upcoming Meetings


July 4-6, 2019

 

12th Summer School of the Hellenic Atherosclerosis Society focused on "Treatment of everyday patients with established cardiovascular disease or cardiometabolic risk factors: Interactive Discussion of Clinical Cases"
Athens, Greece

View Meeting Website

July 11, 2019
 

Cardiovascular Disease Prevention Symposium
A one-day conference conjunction with the SCCT Annual Scientific Meeting (July 11-14)

Baltimore, MS, USA


 


July 11-13, 2019

Symposium on Cardiology, Diabetes & Nephrology at the Limits
São Paulo, Brazil

For more information please link to: https://www.atthelimits.org/cardiology-diabetes-nephrology/cdnb-2019 


August-December, 2019

 

Online Course on "Update in Nutrition"
Chilean Working Group on Atherosclerosis


 

August 16-17, 2019
 

17th Brazilian Congress of Atherosclerosis
São Paulo, Brazil

 


August  17-18, 2019

LIACON2019 and 4th Lipid Cerification Course
Dwarka, New Delhi, India

View Meeting Website

August 17-23, 2019

 

10th Anniversary iARS (International Atherosclerosis Researach School)

Prague, Czech Republic

View Meeting Information

August 17-23, 2019

 

18th HDL Workshop on "Structure Function and Therapeutic Applications"
PValencia, Spain 

https://hdl2019.yoursecretariat.com.au


For a complete listing of all Member Society Meetings and educational activities

 

 

Acknowledgements
The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission: Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Amryt, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, Kaneka Europe, Kowa Company, Ltd., Ono Pharmaceutical Co., Ltd., OSLA - Oman Society of Lipids and Atherosclerosis, Otsuka Pharmaceutical Co., Ltd., Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College.
>> Back To Top <<
 
IAS Newsletter Editors
&
Website Editorial Board
 
Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta, PhD
Milan, Italy

Emanuela Folco, PhD
Milan, Italy

Website & Newsletter Editors
Elena Colombo
Milan, Italy
Yelonda Williams, BA
Dallas, TX, USA


Offices:
 Executive Director

Emanuela Folco, Ph.D.
International Atherosclerosis Society
Viale Piave 35 
20129 Milan, Italy 
Tel: +39 02 29006267
Fax: +39 02 29007018
E-mail: emanuela.folco@athero.org; info@athero.org
 

US Office:
International Atherosclerosis Society 
C/O SobelCo
50 Tice Boulevard, Suite 175
Woodcliff Lake, NJ 07677, USA
E-mail: info@athero.org
************************************************************************************************************************************************************

You are a valued member of the International Atherosclerosis Society. You are receiving this email because you opted in at our website - www.athero.org

Unsubscribe <<Email Address>> from this list.

Our mailing address is:
International Atherosclerosis Society
Fondazione Giovanni Lorenzini Medical Science Foundation
viale Piave 35
Milan, Italy 20129
Italy

Add us to your address book

Copyright (C) 2019 International Atherosclerosis Society All rights reserved.

Forward this email to a friend
Update your profile